- Home
- Publications
- Publication Search
- Publication Details
Title
Dengue Fever: Causes, Complications, and Vaccine Strategies
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2016-07-21
DOI
10.1155/2016/6803098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET INFECTIOUS DISEASES
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
- (2015) Kristen Bauer et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Animal models for studying dengue pathogenesis and therapy
- (2015) Kitti Wing Ki Chan et al. ANTIVIRAL RESEARCH
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Dengue vaccines: Challenges, development, current status and prospects
- (2015) L Dar et al. Indian Journal of Medical Microbiology
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue vaccines at a crossroad
- (2015) A. Wilder-Smith et al. SCIENCE
- Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
- (2015) G. Fibriansah et al. SCIENCE
- Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
- (2015) P. Robert Beatty et al. Science Translational Medicine
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
- (2015) Naphak Modhiran et al. Science Translational Medicine
- Preclinical and clinical development of a dengue recombinant subunit vaccine
- (2015) Susan B. Manoff et al. VACCINE
- Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
- (2015) Dhanasekaran Govindarajan et al. VACCINE
- Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine
- (2015) Alexander Roberto Precioso et al. VACCINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
- (2014) Jorge E Osorio et al. LANCET INFECTIOUS DISEASES
- Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
- (2014) William B. Messer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coupling of replication and assembly in flaviviruses
- (2014) Swapna Apte-Sengupta et al. Current Opinion in Virology
- Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
- (2014) Carolina De La Guardia et al. Biomed Research International
- T-Cell Immunity to Infection with Dengue Virus in Humans
- (2014) Daniela Weiskopf et al. Frontiers in Immunology
- Mouse Models to Study Dengue Virus Immunology and Pathogenesis
- (2014) Raphaël M. Zellweger et al. Frontiers in Immunology
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
- (2013) Gustavo H. Dayan et al. VACCINE
- A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
- (2012) Stephen J. Thomas et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Aedes albopictus and the reemergence of Dengue
- (2012) Giovanni Rezza BMC PUBLIC HEALTH
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A dengue DNA vaccine formulated with Vaxfectin®is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
- (2012) Kanakatte Raviprakash et al. Human Vaccines & Immunotherapeutics
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
- (2012) Oliver J. Brady et al. PLoS Neglected Tropical Diseases
- Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
- (2011) Jorge E. Osorio et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants
- (2011) Veerachai Watanaveeradej et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immune Response to Dengue Virus and Prospects for a Vaccine
- (2011) Brian R. Murphy et al. Annual Review of Immunology
- Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries
- (2011) Judit Barniol et al. BMC INFECTIOUS DISEASES
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- Development of dengue DNA vaccines
- (2011) Janine R. Danko et al. VACCINE
- Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
- (2011) Kevin R. Porter et al. VACCINE
- Dengue — Quo tu et quo vadis?
- (2011) Rubing Chen et al. Viruses-Basel
- Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
- (2011) Federico Narvaez et al. PLoS Neglected Tropical Diseases
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults
- (2010) Wellington Sun et al. Human vaccines & immunotherapeutics
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
- (2010) Dennis Morrison et al. JOURNAL OF INFECTIOUS DISEASES
- Different Innate Signatures Induced in Human Monocyte-derived Dendritic Cells by Wild-Type Dengue 3 Virus, Attenuated but Reactogenic Dengue 3 Vaccine Virus, or Attenuated Nonreactogenic Dengue 1-4 Vaccine Virus Strains
- (2010) C. Balas et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Closing the door on flaviviruses: Entry as a target for antiviral drug design
- (2008) Rushika Perera et al. ANTIVIRAL RESEARCH
- Structural proteomics of dengue virus
- (2008) Rushika Perera et al. CURRENT OPINION IN MICROBIOLOGY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
- (2008) R. Suzuki et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started